EU: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in the EU

For the fifth consecutive year, the EU medicaments containing corticosteroid hormones market recorded growth in sales value, which increased by 3.3% to $X in 2021. Over the period under review, consumption enjoyed a buoyant expansion. Over the period under review, the market hit record highs in 2021 and is likely to see gradual growth in the near future.

Production of Medicaments Containing Corticosteroid Hormones in the EU

In value terms, medicaments containing corticosteroid hormones production reached $X in 2021 estimated in export price. Over the period under review, production, however, enjoyed a resilient expansion. The most prominent rate of growth was recorded in 2018 when the production volume increased by 37%. The level of production peaked in 2021 and is expected to retain growth in the near future.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in the EU

In 2021, overseas shipments of medicaments containing corticosteroid hormones decreased by -1.4% to X tons for the first time since 2015, thus ending a five-year rising trend. The total export volume increased at an average annual rate of +5.7% from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2014 with an increase of 15%. The volume of export peaked at X tons in 2020, and then shrank in the following year.

In value terms, medicaments containing corticosteroid hormones exports rose modestly to $X in 2021. Total exports indicated a buoyant increase from 2012 to 2021: its value increased at an average annual rate of +7.3% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +78.0% against 2015 indices. The pace of growth appeared the most rapid in 2013 when exports increased by 29%. The level of export peaked in 2021 and is expected to retain growth in years to come.

Exports by Country

The shipments of the four major exporters of medicaments containing corticosteroid hormones, namely Italy, France, Germany and Belgium, represented more than half of total export. It was distantly followed by Spain (X tons), Sweden (X tons), the Netherlands (X tons) and Ireland (X tons), together creating a 24% share of total exports.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Spain (with a CAGR of +13.0%), while the other leaders experienced more modest paces of growth.

In value terms, Italy ($X), Germany ($X) and France ($X) appeared to be the countries with the highest levels of exports in 2021, with a combined 50% share of total exports. Belgium, the Netherlands, Ireland, Sweden and Spain lagged somewhat behind, together accounting for a further 36%.

In terms of the main exporting countries, the Netherlands, with a CAGR of +15.7%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in the European Union stood at $X per ton in 2021, increasing by 5.3% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +1.5%. The pace of growth was the most pronounced in 2020 an increase of 17% against the previous year. The level of export peaked in 2021 and is expected to retain growth in years to come.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was the Netherlands ($X per ton), while Spain ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Ireland (+8.3%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in the EU

In 2021, purchases abroad of medicaments containing corticosteroid hormones increased by 7.9% to X tons, rising for the fifth year in a row after three years of decline. Total imports indicated a prominent increase from 2012 to 2021: its volume increased at an average annual rate of +7.2% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +81.5% against 2016 indices. The growth pace was the most rapid in 2013 with an increase of 27% against the previous year. Over the period under review, imports attained the maximum in 2021 and are expected to retain growth in years to come.

In value terms, medicaments containing corticosteroid hormones imports totaled $X in 2021. Overall, imports saw a resilient increase. The pace of growth appeared the most rapid in 2020 with an increase of 26%. The level of import peaked in 2021 and is likely to continue growth in the near future.

Imports by Country

Denmark was the largest importer of medicaments containing corticosteroid hormones in the European Union, with the volume of imports finishing at X tons, which was near 29% of total imports in 2021. It was distantly followed by Belgium (X tons), France (X tons), Italy (X tons), Germany (X tons), Spain (X tons) and the Netherlands (X tons), together comprising a 52% share of total imports.

Denmark was also the fastest-growing in terms of the medicaments containing corticosteroid hormones imports, with a CAGR of +54.9% from 2012 to 2021. At the same time, the Netherlands (+12.6%), Italy (+12.4%), Germany (+8.6%) and Belgium (+8.0%) displayed positive paces of growth. By contrast, France (-1.3%) and Spain (-6.0%) illustrated a downward trend over the same period. From 2012 to 2021, the share of Denmark, Italy and the Netherlands increased by +28, +3 and +2 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest medicaments containing corticosteroid hormones importing markets in the European Union were Italy ($X), Belgium ($X) and Germany ($X), with a combined 51% share of total imports. These countries were followed by the Netherlands, France, Denmark and Spain, which together accounted for a further 32%.

Denmark, with a CAGR of +31.7%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the import price in the European Union amounted to $X per ton, declining by -2.2% against the previous year. Over the last nine years, it increased at an average annual rate of +2.5%. The pace of growth appeared the most rapid in 2016 when the import price increased by 16%. Over the period under review, import prices attained the maximum at $X per ton in 2020, and then fell in the following year.

Prices varied noticeably country of destination: the country with the highest price was Italy ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Spain (+9.6%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :